Filed in archive
Drugs, Vaccines and Therapeutics
, Gene Therapy
, Nanomedicine
by ruth on January 17, 2007
In addition to surgery, radiation and chemotherapy, there may now be an additional treatment modality for cancers: dual gene therapy.
In a preclinical study, two tumor-suppressing genes, packaged in a nanoparticle delivery system, were intravenuously administered and has been shown to reduce the number by and size of human non-small cell lung cancer tumors in mice by 75-80%.
Read more about the methodology and further findings from the MD Anderson Cancer Center news release.
In a preclinical study, two tumor-suppressing genes, packaged in a nanoparticle delivery system, were intravenuously administered and has been shown to reduce the number by and size of human non-small cell lung cancer tumors in mice by 75-80%.
The genes wrapped in the nanoparticles were p53, a well-known tumor suppressor that works by causing defective cells to commit suicide and is often shut down or defective in cancer cells, and FUS1, a tumor-suppressor discovered by the research group that is deficient in most human lung cancers. Each nanoparticle carried one of the two genes.
Read more about the methodology and further findings from the MD Anderson Cancer Center news release.
Permalink: Dual Gene Therapy Against Lung Cancer
Tags:
gene+therapy
cancer
lung+cancer
chemotherapy
nanomedicine
nanotechnology
therapy
therapy+against
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/49855
Mr Wong
Vote for Dual Gene Therapy Against Lung Cancer:
|
Rating: 9.40 out of 5 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |








